Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 7/20 | 0.58 |
| ▸ | MMP9 | P14780 | 1/20 | 0.53 |
| ▸ | REN | P00797 | 1/20 | 0.52 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.52 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.51 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.51 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.51 |
| ▸ | CTSB | P07858 | 3/20 | 0.50 |
| ▸ | CTSS | P25774 | 3/20 | 0.50 |
| ▸ | CTSL | P07711 | 2/20 | 0.50 |
| ▸ | MME | P08473 | 1/20 | 0.50 |
| ▸ | ECE1 | P42892 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30902886 | 1.00 | CTSK (0.58) | CTSKMMP9RENCAPN1PSMB8 | |
| SCHEMBL21523352 | 0.92 | MME (0.55) | CTSKMMP9RENCAPN1PSMB8 | |
| SCHEMBL21523353 | 0.92 | MME (0.55) | CTSKMMP9RENCAPN1PSMB8 | |
| SCHEMBL20323161 | 0.92 | MME (0.55) | CTSKMMP9RENCAPN1PSMB8 | |
| SCHEMBL14433707 | 0.91 | MME (0.59) | CTSKCAPN1PSMB8PSMB9PSMB5 | |
| SCHEMBL4430771 | 0.91 | MME (0.59) | CTSKCAPN1PSMB8PSMB9PSMB5 | |
| SCHEMBL7155003 | 0.91 | MME (0.59) | CTSKCAPN1PSMB8PSMB9PSMB5 | |
| SCHEMBL29453232 | 0.90 | MME (0.58) | CTSKCAPN1PSMB8PSMB9PSMB5 | |
| SCHEMBL18342569 | 0.90 | CTSK (0.55) | CTSKRENCAPN1PSMB8PSMB9 | |
| SCHEMBL20263594 | 0.90 | CTSK (0.55) | CTSKRENCAPN1PSMB8PSMB9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024105205-A1 | ANTIBODY-DRUG CONJUGATES (A2DCS) WITH ENZYMATICALLY CLEAVABLE GROUPS | BAYER AKTIENGESELLSCHAFT (DE) | 2024-05-23 | — | — | WO | disclosed |